Cargando…
Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies
OBJECTIVE: This study aimed to evaluate the oxidant–antioxidant status of amniotic fluid in pregnant women with foetal congenital malformations of the central nervous system. METHODS: We studied pregnant women with foetal congenital nervous system anomalies at 16–22 weeks’ gestation (n = 36). The co...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972242/ https://www.ncbi.nlm.nih.gov/pubmed/29210307 http://dx.doi.org/10.1177/0300060517734443 |
_version_ | 1783326401262256128 |
---|---|
author | Cim, Numan Tolunay, Harun Egemen Karaman, Erbil Boza, Barıs Bilici, Mustafa Çetin, Orkun Yıldızhan, Recep Sahin, Hanım Guler |
author_facet | Cim, Numan Tolunay, Harun Egemen Karaman, Erbil Boza, Barıs Bilici, Mustafa Çetin, Orkun Yıldızhan, Recep Sahin, Hanım Guler |
author_sort | Cim, Numan |
collection | PubMed |
description | OBJECTIVE: This study aimed to evaluate the oxidant–antioxidant status of amniotic fluid in pregnant women with foetal congenital malformations of the central nervous system. METHODS: We studied pregnant women with foetal congenital nervous system anomalies at 16–22 weeks’ gestation (n = 36). The control group (n = 30) consisted of pregnant women at the same gestational age who underwent amniocentesis, resulting in a normal karyotype. We analysed glutathione, catalase, and malondialdehyde levels in amniotic fluid. Enzyme activation was measured by spectrophotometry. RESULTS: The demographic features of the groups were similar in terms of age, parity, body mass index, and gestational weeks. We detected lower glutathione and catalase levels in the foetal congenital anomaly group than in the control group. We detected higher malondialdehyde levels in the foetal congenital anomaly group than in the control group. CONCLUSION: In the organism, the rate of formation of free radicals and their rate of removal are balanced, and this is called oxidative balance. As long as oxidative stability is achieved, the organism is not affected by free radicals. This fact should be kept in mind to avoid any type of teratogenic agent that could lead to congenital disorders. |
format | Online Article Text |
id | pubmed-5972242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-59722422018-05-31 Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies Cim, Numan Tolunay, Harun Egemen Karaman, Erbil Boza, Barıs Bilici, Mustafa Çetin, Orkun Yıldızhan, Recep Sahin, Hanım Guler J Int Med Res Clinical Reports OBJECTIVE: This study aimed to evaluate the oxidant–antioxidant status of amniotic fluid in pregnant women with foetal congenital malformations of the central nervous system. METHODS: We studied pregnant women with foetal congenital nervous system anomalies at 16–22 weeks’ gestation (n = 36). The control group (n = 30) consisted of pregnant women at the same gestational age who underwent amniocentesis, resulting in a normal karyotype. We analysed glutathione, catalase, and malondialdehyde levels in amniotic fluid. Enzyme activation was measured by spectrophotometry. RESULTS: The demographic features of the groups were similar in terms of age, parity, body mass index, and gestational weeks. We detected lower glutathione and catalase levels in the foetal congenital anomaly group than in the control group. We detected higher malondialdehyde levels in the foetal congenital anomaly group than in the control group. CONCLUSION: In the organism, the rate of formation of free radicals and their rate of removal are balanced, and this is called oxidative balance. As long as oxidative stability is achieved, the organism is not affected by free radicals. This fact should be kept in mind to avoid any type of teratogenic agent that could lead to congenital disorders. SAGE Publications 2017-12-06 2018-03 /pmc/articles/PMC5972242/ /pubmed/29210307 http://dx.doi.org/10.1177/0300060517734443 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Clinical Reports Cim, Numan Tolunay, Harun Egemen Karaman, Erbil Boza, Barıs Bilici, Mustafa Çetin, Orkun Yıldızhan, Recep Sahin, Hanım Guler Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies |
title | Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies |
title_full | Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies |
title_fullStr | Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies |
title_full_unstemmed | Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies |
title_short | Amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies |
title_sort | amniotic fluid oxidant–antioxidant status in foetal congenital nervous system anomalies |
topic | Clinical Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972242/ https://www.ncbi.nlm.nih.gov/pubmed/29210307 http://dx.doi.org/10.1177/0300060517734443 |
work_keys_str_mv | AT cimnuman amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies AT tolunayharunegemen amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies AT karamanerbil amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies AT bozabarıs amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies AT bilicimustafa amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies AT cetinorkun amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies AT yıldızhanrecep amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies AT sahinhanımguler amnioticfluidoxidantantioxidantstatusinfoetalcongenitalnervoussystemanomalies |